Laser Vein Treatment

Men and women can make unsightly facial and leg veins a thing of the past with Cutera CoolGlide. Using the most advanced technology, a unique design, and a longer wavelength, Cutera CoolGlide safely and effectively treats tiny superficial face veins and deeper blue leg veins on all skin tones.

WHAT IS CUTERA COOLGLIDE VEIN THERAPY?

Cutera CoolGlide Vein Therapy for the face and body is a vascular laser that’s designed to treat blood vessels that are close to the surface, giving skin the appearance of uneven redness. This system can be used to treat tiny spider veins that usually cause redness on the face, as well as the deep blue reticular veins that form clusters on legs.

HOW DOES VEIN THERAPY WORK WITH THE CUTERA COOLGLIDE LASER?

The system delivers pulses of energy that cause the blood within the vein to coagulate and destroy the vessel, which is then absorbed back into your body. Blood flow is then redirected to veins deeper below your skin’s surface, as it should be.

HOW MANY LASER VEIN TREATMENTS WILL I NEED?

Patients often find that one or two vein therapy treatments are sufficient. However, the number of treatments necessary depends on the number, color, and size of the vessels being treated. Since individual results vary, we will meet with you to discuss your specific condition and expected number of treatments.

WHEN WILL I SEE RESULTS AFTER CUTERA COOLGLIDE?

Most patients see significant improvement of the treated veins within two to six weeks of procedure. However, final results may take several months to become evident. It is possible for new veins to appear again over time, but these too can be removed with the Cutera CoolGlide.

IS CUTERA COOLGLIDE VEIN THERAPY SAFE FOR ALL SKIN TYPES?

The Cutera CoolGlide laser is safe for use on all skin tones.

SCHEDULE YOUR VEIN TREATMENT TODAY

To learn more about the Cutera CoolGlide system offered at MD Coté Medical Spa, schedule a consultation by calling 425.321.3692. Our premier medical spa serves Maple Valley, WA & nearby areas.